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Dear editor
The strong association between the metabolic derangements that characterize the 
metabolic syndrome with arterial hypertension is very well-known, as it is the 
common finding of hyperuricemia in the patients with the metabolic syndrome. 
Besides, hyperuricemia has been found to be associated with cardiovascular, renal, 
and metabolic diseases; including not only gout but also type 2 diabetes mellitus, 
although its role as a risk factor is still debated.1 We were not aware of previous studies 
describing an association between uric acid levels and the non-dipping 24-hour blood 
pressure (BP) pattern, and for that reason we were intrigued by Tutal et al’s article, 
regarding hypertensive patients with the metabolic syndrome.2 The authors explain 
some possible causes that could determine an increase in uric acid in the metabolic 
syndrome, and describe some pathogenetic mechanisms of systemic hypertension in 
their patients. We would like to point out one more possible mechanism that could 
link hyperuricemia to non-dipping BP.
Obstructive sleep apnea syndrome (OSAS) is characterized by recurrent upper 
airway obstruction during sleep. Each apneic episode resulting from the obstruction 
is followed by an increase in both heart rate and BP, which can often feature a short 
hypertensive peak.3 Although BP peaks usually last only few seconds, they can be 
numerous during the night, and can be responsible for a reduced or absent fall in mean 
nocturnal BP,4 which may be detected with 24-hour ambulatory BP monitoring, ie, with 
the same technique adopted by Tutal et al2 in their study. An attenuation of nocturnal 
BP fall may also be observed in non-apneic subjects with partial upper airway obstruc-
tion and continuous snoring.5 Other studies have also shown an increase in morning 
BP in patients with OSAS, especially soon after awakening.6
OSAS is more common in obese subjects, especially if they are male and have an 
increased waist-to-hip ratio, and is very often associated with the metabolic syndrome.7 
Among the components of the metabolic syndrome, systemic hypertension is the most 
strictly associated with OSAS.8 According to several studies, atherogenic dyslipidemia, 
with increased total and low density lipoprotein (LDL) cholesterol, and decreased high 
density lipoprotein (HDL) cholesterol, are also associated with OSAS.9
Although there has been some controversy, according to most studies a link 
between OSAS and increased uric acid actually exists. The increased uric acid level 
in OSAS is believed to be a consequence of tissue hypoxia due to apneas, which could 
cause an increase in adenosine triphosphate catabolism, with a consequent increase 
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in purines whose degradation turns into increased uric acid 
production. In fact, tissue hypoxia is not tightly correlated to 
arterial hypoxia. That may make it difficult to find a correla-
tion between oxyhemoglobin saturation measured during the 
night and uric acid, and may mask the relationship between 
OSAS severity and uric acid production.10 However, a recent 
epidemiological study on a large cohort clearly demonstrated 
a relationship between uric acid levels and the rate of sleep 
respiratory disorders (apnea/hypopnea index [AHI]).11
In their sample, Tutal et al2 also observed a relationship 
between uric acid level and waist-to-hip ratio, LDL choles-
terol and nocturnal diastolic BP, morning BP surge. Since 
all these factors are very often associated with OSAS, we 
believe that the patients studied by Tutal et al2 were very 
likely affected by OSAS.
The metabolic syndrome with all its components 
(insulin resistance, dyslipidemia, visceral obesity, arterial 
hypertension), hyperuricemia and OSAS are tightly inter-
related, so that it is difficult to establish to what extent each 
of them is a cause or an effect of the other. We would like to 
point out that OSAS could represent an important factor link-
ing hyperuricemia and non-dipping 24-hour BP in patients 
with the metabolic syndrome.
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